IntraVu
Redwood City, US · Delaware corporation
Founders & leadership
TK
Theofilos KotseroglouNamed on SEC filing
SP
Stephanos PapademetriouNamed on SEC filing
SB
Spiros BouasNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$26.5M disclosed across 2 rounds · 2019–2021
▶$14.9MraisedAug 2021 · 42 investors · BiotechnologyRule 506(b)
▶$14.9MraisedAug 2021 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephanos PapademetriouExecutive Officer, Director
- Tehofilos KotseroglouDirector
- Spiros BouasDirector
- Offering amount
- $14.9M
- Amount sold
- $14.9M
- Minimum investment
- $20K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.7MraisedDec 2019 · 53 investors · BiotechnologyRule 506(b)
▶$11.7MraisedDec 2019 · 53 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Theofilos KotseroglouExecutive Officer, Director
- Stephanos PapademetriouExecutive Officer, Director
- Spiros BouasDirector
- Offering amount
- $11.7M
- Amount sold
- $11.7M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has IntraVu raised?
- IntraVu has disclosed $26.5M raised across 2 rounds.
- Where is IntraVu headquartered?
- IntraVu is headquartered in Redwood City, US.